In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease
Yuki Maeda(Kumamoto University), Hidetoshi Arima(Daiichi University of Pharmacy)
Cited by 20
Related Papers
Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy
|Biological and Pharmaceutical Bulletin|2019|12